Clinical trial
Post-marketing Observational Study for Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
NCT04750213 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-marketing Observational Study for Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 12, 2021
- Completion date
- November 11, 2024
- Enrollment
- 60 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.